Stock News

As Mfs Invt Grade Mun Tr Sh Ben Int (CXH) Stock Price Declined, Karpus Management Upped by $704,565 Its Stake; Daniel Devine & Company Has Lowered Johnson & Johnson (JNJ) Position as Stock Value Declined

Johnson & Johnson (NYSE:JNJ) Logo

Daniel Devine & Company decreased its stake in Johnson & Johnson (JNJ) by 14.34% based on its latest 2018Q1 regulatory filing with the SEC. Daniel Devine & Company sold 5,100 shares as the company’s stock declined 8.03% with the market. The institutional investor held 30,457 shares of the major pharmaceuticals company at the end of 2018Q1, valued at $3.90M, down from 35,557 at the end of the previous reported quarter. Daniel Devine & Company who had been investing in Johnson & Johnson for a number of months, seems to be less bullish one the $330.17B market cap company. The stock increased 0.46% or $0.56 during the last trading session, reaching $123.1. About 2.88M shares traded. Johnson & Johnson (NYSE:JNJ) has declined 4.75% since June 13, 2017 and is downtrending. It has underperformed by 17.32% the S&P500. Some Historical JNJ News: 27/03/2018 – FDA: Johnson & Johnson Consumer, Inc.- COACH® Self-Adhering Sports Wrap (size: 2in); 26/03/2018 – Hartford Dividend & Growth HLS Adds AT&T, Cuts J&J; 25/05/2018 – SOUTH CAROLINA JUDGE DECLARES MISTRIAL IN J&J TALC TRIAL; 21/05/2018 – JANSSEN PHARMACEUTICAL – VIIV HEALTHCARE WILL MARKET DOLUTEGRAVIR/RILPIVIRINE IN COUNTRIES IN EUROPEAN UNION & EUROPEAN ECONOMIC AREA; 22/03/2018 – Johnson & Johnson CDS Widens 3 Bps, Most in 6 Months; 16/04/2018 – JANSSEN – UNDER AGREEMENT, CO, BRISTOL-MYERS SQUIBB TO ADVANCE BMS-986177 INTO PHASE 2 CLINICAL TRIALS; 11/04/2018 – Johnson & Johnson Vision Announces Contact Lens Innovation With ACUVUE OASYS With Transitions Light Intelligent Technology; 29/03/2018 – Arkansas sues opioid manufacturers for roles in epidemic; 17/04/2018 – JNJ 1Q EARNINGS CALLS ENDS; 17/04/2018 – J&J – QTRLY WORLDWIDE ZYTIGA SALES $845 MLN VS $523 MLN REPORTED LAST YR

Karpus Management Inc increased its stake in Mfs Invt Grade Mun Tr Sh Ben Int (CXH) by 5% based on its latest 2018Q1 regulatory filing with the SEC. Karpus Management Inc bought 78,285 shares as the company’s stock declined 1.29% with the market. The institutional investor held 1.64M shares of the company at the end of 2018Q1, valued at $15.44M, up from 1.57 million at the end of the previous reported quarter. Karpus Management Inc who had been investing in Mfs Invt Grade Mun Tr Sh Ben Int for a number of months, seems to be bullish on the $90.51 million market cap company. It closed at $9.19 lastly. It is down 9.00% since June 13, 2017 and is downtrending. It has underperformed by 21.57% the S&P500.

Investors sentiment decreased to 1.13 in 2018 Q1. Its down 0.54, from 1.67 in 2017Q4. It is negative, as 2 investors sold CXH shares while 6 reduced holdings. 6 funds opened positions while 3 raised stakes. 2.74 million shares or 1.42% more from 2.71 million shares in 2017Q4 were reported. Icon Advisers Inc Company reported 213,704 shares. Wells Fargo And Mn reported 0% in MFS Investment Grade Municipal (NYSE:CXH). Yakira Mngmt holds 10,779 shares or 0.02% of its portfolio. Fifth Third National Bank & Trust, a Ohio-based fund reported 9,000 shares. Sit Invest Assoc stated it has 49,240 shares. Pnc Services Grp Inc stated it has 0% of its portfolio in MFS Investment Grade Municipal (NYSE:CXH). Lpl Fincl Lc reported 0% of its portfolio in MFS Investment Grade Municipal (NYSE:CXH). Advsr Asset invested in 0.07% or 418,631 shares. Webster Commercial Bank N A has invested 0.01% in MFS Investment Grade Municipal (NYSE:CXH). Dynamic Advisor Solutions Limited Liability Co has invested 0.03% in MFS Investment Grade Municipal (NYSE:CXH). Janney Montgomery Scott Limited Liability Corp stated it has 22,454 shares or 0% of all its holdings. Bank Of America De stated it has 0% of its portfolio in MFS Investment Grade Municipal (NYSE:CXH). Ameriprise has invested 0% in MFS Investment Grade Municipal (NYSE:CXH). Live Your Vision Limited Liability Corp owns 1,000 shares. Clough Cap Prtnrs Lp owns 0.02% invested in MFS Investment Grade Municipal (NYSE:CXH) for 19,144 shares.

Karpus Management Inc, which manages about $2.60B and $2.23B US Long portfolio, decreased its stake in Kbl Merger Corp. Iv by 50,750 shares to 1.63 million shares, valued at $16.09 million in 2018Q1, according to the filing. It also reduced its holding in Vanguard Interm (VCIT) by 77,735 shares in the quarter, leaving it with 150,780 shares, and cut its stake in Blackrock Core Bd Tr Shs Ben Int (BHK).

Since February 15, 2018, it had 0 buys, and 1 sale for $20.17 million activity.

Investors sentiment increased to 0.93 in 2018 Q1. Its up 0.06, from 0.87 in 2017Q4. It is positive, as 63 investors sold JNJ shares while 831 reduced holdings. 111 funds opened positions while 720 raised stakes. 1.71 billion shares or 0.80% less from 1.72 billion shares in 2017Q4 were reported. Fidelity Natl Finance owns 58,480 shares for 1.11% of their portfolio. Meristem Limited Liability Partnership reported 1.46% stake. Kentucky Retirement Insurance Trust Fund owns 1.55% invested in Johnson & Johnson (NYSE:JNJ) for 61,420 shares. Mcgowan Asset Mngmt invested 0.08% of its portfolio in Johnson & Johnson (NYSE:JNJ). New Jersey Better Educational Savings Tru stated it has 1.71% of its portfolio in Johnson & Johnson (NYSE:JNJ). Moreover, Ing Groep Nv has 1.98% invested in Johnson & Johnson (NYSE:JNJ). Advisory Services Network Limited Liability holds 0.63% or 61,712 shares. First Fiduciary Investment Counsel Inc stated it has 136,100 shares. Tiemann Ltd Liability Corporation holds 19,773 shares or 2.04% of its portfolio. Windward Capital Mngmt Ca holds 98,240 shares. Manufacturers Life Insurance The reported 1% of its portfolio in Johnson & Johnson (NYSE:JNJ). Tompkins Corporation has invested 1.41% in Johnson & Johnson (NYSE:JNJ). First Western Capital Co stated it has 2.45% of its portfolio in Johnson & Johnson (NYSE:JNJ). Symphony Asset Management Limited Liability owns 29,337 shares or 0.48% of their US portfolio. Baldwin Brothers Inc Ma has invested 0.8% in Johnson & Johnson (NYSE:JNJ).

Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 11 have Buy rating, 5 Sell and 7 Hold. Therefore 48% are positive. Johnson & Johnson had 102 analyst reports since August 7, 2015 according to SRatingsIntel. On Friday, July 21 the stock rating was downgraded by BTIG Research to “Sell”. RBC Capital Markets maintained Johnson & Johnson (NYSE:JNJ) on Wednesday, July 20 with “Outperform” rating. The company was maintained on Thursday, October 19 by Credit Suisse. Vetr downgraded the shares of JNJ in report on Monday, August 31 to “Strong-Buy” rating. RBC Capital Markets maintained the stock with “Buy” rating in Monday, July 10 report. The firm has “Equal-Weight” rating by Morgan Stanley given on Tuesday, April 10. Jefferies maintained Johnson & Johnson (NYSE:JNJ) rating on Friday, June 16. Jefferies has “Hold” rating and $140 target. BMO Capital Markets maintained the stock with “Buy” rating in Tuesday, October 17 report. The firm has “Neutral” rating by Piper Jaffray given on Monday, October 5. As per Wednesday, October 19, the company rating was maintained by UBS.

More notable recent Johnson & Johnson (NYSE:JNJ) news were published by: Streetinsider.com which released: “Johnson & Johnson (JNJ) Announces Acceptance of Binding Offer From Platinum Equity To Acquire LifeScan for $2.1 …” on June 12, 2018, also Seekingalpha.com with their article: “Johnson & Johnson (JNJ) Presents at Goldman Sachs 39th Annual Global Healthcare Conference Call (Transcript)” published on June 12, 2018, Seekingalpha.com published: “Fortive buys J&J’s sterilization business for $2.7B” on June 06, 2018. More interesting news about Johnson & Johnson (NYSE:JNJ) were released by: Seekingalpha.com and their article: “Johnson & Johnson: Recent Price Drop Offers Opportunity” published on June 13, 2018 as well as Livetradingnews.com‘s news article titled: “Johnson & Johnson (NYSE:JNJ) Stock Worth Watching” with publication date: June 04, 2018.

Johnson & Johnson (NYSE:JNJ) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *